Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy

Recently, boron neutron capture therapy (BNCT) has been attracting attention as a minimally invasive cancer treatment. In 2020, the accelerator-based BNCT with L-BPA (Borofalan) as its D-sorbitol complex (Steboronine®) for head and neck cancers was approved by Pharmaceutical and Medical Devices Agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Yoshihide, Andoh, Tooru, Kawabata, Shinji, Hu, Naonori, Michiue, Hiroyuki, Nakamura, Hiroyuki, Nomoto, Takahiro, Suzuki, Minoru, Takata, Takushi, Tanaka, Hiroki, Watanabe, Tsubasa, Ono, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665309/
https://www.ncbi.nlm.nih.gov/pubmed/37717596
http://dx.doi.org/10.1093/jrr/rrad064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665309/
https://www.ncbi.nlm.nih.gov/pubmed/37717596
http://dx.doi.org/10.1093/jrr/rrad064

Ejemplares similares